The potential oncogenic nature of Fli-1 was previously demonstrated in erythroblastic leukemia, wherein Fli-1 was shown to induce the proliferation of differentiation-arrested erythroblasts with longer survival of Fli-1 expressing with BCL2 expression [26]. Here, FLI1 is linked to acute erythroid leukemia.